IDO1 and melanoma: Rebekka et al. showed that tumor-infiltrating M-MDSC were inhibited by CSF1R inhibitor PLX647 in B16 IDO-expressed melanoma mouse model, where the co-blockade of PD-1 and CTLA-4 were sensitized in via T cell activation (148).